Velocity Clinical Research Partners with Verified Clinical Trials to combat double enrollment problem in clinical trials

Core Insights - Velocity Clinical Research has partnered with Verified Clinical Trials (VCT) to enhance patient safety and data quality in clinical trials through new technology implementation across its 80+ global sites [1][4][5] Industry Challenge - The collaboration addresses the critical issue of double enrollment of participants in multiple studies, which can jeopardize patient health, compromise data integrity, and increase drug development costs for Sponsors and CROs [2][5] Technological Implementation - VCT's advanced participant verification technology will prevent participants from enrolling in two studies simultaneously, ensuring safety and data reliability by flagging those already engaged in another trial [4][6] Commitment to Safety and Integrity - Velocity's initiative reflects its commitment to patient safety and data integrity, setting a higher standard in the industry by addressing the widespread issue of duplicate enrollment [5][9] Operational Efficiency - The partnership is facilitated by Advarra's Clinical Conductor system, which enables seamless processing of enrollment status data, enhancing accuracy and reducing administrative burdens for Sponsors and CROs [6][8] Company Overview - Velocity Clinical Research operates over 80 sites with 220 investigators, partnering with pharmaceutical and biotechnology companies to conduct clinical trials aimed at improving human health [7][8] VCT Overview - VCT manages the world's largest research participant registry, designed to prevent dual enrollment and provide protocol violation protections, having supported over 10,000 clinical trials to date [9]